A recent study by Li and colleagues identified that GATA3 could reduce extracellular ATP (eATP) in the breast cancer microenvironment by upregulating ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3), an eATP hydrolytic enzyme [35]. The gene discussed is GATA3; the disease is breast carcinoma.